PMVP – pmv pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $5.00 price target on the stock.
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors [Yahoo! Finance]
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer [Yahoo! Finance]
Form ARS PMV Pharmaceuticals, For: Dec 31
Form DEFA14A PMV Pharmaceuticals,
Form DEF 14A PMV Pharmaceuticals, For: Jun 06
Form SC 13G/A PMV Pharmaceuticals, Filed by: JPMORGAN CHASE & CO
Form 10-K PMV Pharmaceuticals, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.